These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33639244)

  • 41. Minoxidil induced hypertrichosis in children.
    Guerouaz N; Mohamed AO
    Pan Afr Med J; 2014; 18():8. PubMed ID: 25360192
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
    J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generalized Hypertrichosis Due to Topical Minoxidil.
    Gargallo V; Gutierrez C; Vanaclocha F; Guerra-Tapia A
    Actas Dermosifiliogr; 2015 Sep; 106(7):599-600. PubMed ID: 25688008
    [No Abstract]   [Full Text] [Related]  

  • 45. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial.
    Ramos PM; Sinclair RD; Kasprzak M; Miot HA
    J Am Acad Dermatol; 2020 Jan; 82(1):252-253. PubMed ID: 31473295
    [No Abstract]   [Full Text] [Related]  

  • 47. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.
    Perera E; Sinclair R
    F1000Res; 2017; 6():1650. PubMed ID: 29167734
    [No Abstract]   [Full Text] [Related]  

  • 50. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Systemic effects of topical minoxidil 2% in children].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008; 135(8-9):629. PubMed ID: 18789307
    [No Abstract]   [Full Text] [Related]  

  • 53. Minoxidil and its use in hair disorders: a review.
    Suchonwanit P; Thammarucha S; Leerunyakul K
    Drug Des Devel Ther; 2019; 13():2777-2786. PubMed ID: 31496654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interventions for female pattern hair loss.
    van Zuuren EJ; Fedorowicz Z; Schoones J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD007628. PubMed ID: 27225981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comment on "Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients".
    Trüeb RM; Luu NC; Rezende HD
    J Am Acad Dermatol; 2022 Jul; 87(1):e29-e30. PubMed ID: 35304167
    [No Abstract]   [Full Text] [Related]  

  • 56. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
    Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
    J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
    [No Abstract]   [Full Text] [Related]  

  • 57. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study.
    Kang J; Lee JW; Kwon O
    J Am Acad Dermatol; 2023 May; 88(5):1170-1173. PubMed ID: 36526083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.